Hayes receives prestigious Susan G. Komen Breast Cancer Research Award

Media contact: Nicole Fawcett, 734-764-2220 |  Patients may contact Cancer AnswerLine™ 800-865-1125

Brinker award honors physician-scientists driving research to improve breast cancer patient outcomes

Daniel F. Hayes, M.D., received the Brinker Award for Clinical Research from Susan G. Komen, the world’s leading breast cancer organization. The award recognizes physician-scientists for their work to drive discoveries and improve breast cancer patient outcomes.

Hayes is the Stuart B. Padnos Professor of Breast Cancer Research at the University of Michigan Rogel Cancer Center and a professor hematology/oncology at Michigan Medicine.

Hayes has created and conducted validations studies for tumor biomarker tests, which are used around the world to predict prognosis, chemotherapy response, recurrence and treatment side effects in patients. His work has accelerated the ability to personalize care and treatment for breast cancer patients and precisely monitor patients after therapy so they get the best treatment.

Komen established the Brinker Award in 1992 to honor leading scientists who have made the most significant achievements and contributions in breast cancer research and clinical practice. The awardees are named for improving our understanding of the underlying mechanisms of breast cancer (Basic Science) and advances in breast cancer care (Clinical Research), which are both critical to fighting the disease.

Hayes was recognized at the Susan G. Komen Breast Cancer Research Awards event in San Antonio.